| | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2025 ( Subtotal = $0 ) |
| 2025 | 2022 | UNIVERSITY OF CALIFORNIA IRVINE | 160 ALDRICH HALL | IRVINE | CA | 92697 | ORANGE | USA | Cancer Treatment Research | 000 | 5 | 10/31/2024 | NON-COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $630,686 ) |
| 2022 | 2022 | UNIVERSITY OF CALIFORNIA, IRVINE | 141 INNOVATION DR STE 250 | IRVINE | CA | 92617 | ORANGE | USA | Cancer Treatment Research | 000 | 5 | 8/12/2022 | NON-COMPETING CONTINUATION | $604,757 |
| 2022 | 2022 | UNIVERSITY OF CALIFORNIA, IRVINE | 141 INNOVATION DR STE 250 | IRVINE | CA | 92617 | ORANGE | USA | Cancer Treatment Research | 001 | 5 | 8/24/2022 | NON-COMPETING CONTINUATION | $0 |
| 2022 | 2022 | UNIVERSITY OF CALIFORNIA, IRVINE | 141 INNOVATION DR STE 250 | IRVINE | CA | 92617 | ORANGE | USA | Cancer Treatment Research | 002 | 5 | 8/24/2022 | SUPPLEMENT FOR EXPANSION | $25,929 |
|
| Issue Date FY: 2021 ( Subtotal = $639,838 ) |
| 2021 | 2021 | UNIVERSITY OF CALIFORNIA, IRVINE | 141 INNOVATION DR STE 250 | IRVINE | CA | 92617 | ORANGE | USA | Cancer Treatment Research | 000 | 4 | 6/17/2021 | NON-COMPETING CONTINUATION | $572,677 |
| 2021 | 2021 | UNIVERSITY OF CALIFORNIA, IRVINE | 141 INNOVATION DR STE 250 | IRVINE | CA | 92617 | ORANGE | USA | Cancer Treatment Research | 001 | 4 | 6/22/2021 | SUPPLEMENT FOR EXPANSION | $67,161 |
|
| Issue Date FY: 2020 ( Subtotal = $641,175 ) |
| 2020 | 2020 | UNIVERSITY OF CALIFORNIA, IRVINE | 141 INNOVATION DR STE 250 | IRVINE | CA | 92617 | ORANGE | USA | Cancer Treatment Research | 000 | 3 | 6/29/2020 | NON-COMPETING CONTINUATION | $641,175 |
|
| Issue Date FY: 2019 ( Subtotal = $640,544 ) |
| 2019 | 2019 | UNIVERSITY OF CALIFORNIA, IRVINE | 141 INNOVATION DR STE 250 | IRVINE | CA | 92617 | ORANGE | USA | Cancer Treatment Research | 000 | 2 | 7/24/2019 | NON-COMPETING CONTINUATION | $640,544 |
|
| Issue Date FY: 2018 ( Subtotal = $716,535 ) |
| 2018 | 2018 | UNIVERSITY OF CALIFORNIA, IRVINE | 141 INNOVATION DR STE 250 | IRVINE | CA | 92617 | ORANGE | USA | Cancer Treatment Research | 000 | 1 | 5/10/2018 | NEW | $716,535 |
|
|